These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 10759911

  • 1. A comparative trial of zolmitriptan and sumatriptan for the acute oral treatment of migraine.
    Gallagher RM, Dennish G, Spierings EL, Chitra R.
    Headache; 2000 Feb; 40(2):119-28. PubMed ID: 10759911
    [Abstract] [Full Text] [Related]

  • 2. Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study.
    Dodick D, Brandes J, Elkind A, Mathew N, Rodichok L.
    CNS Drugs; 2005 Feb; 19(2):125-36. PubMed ID: 15697326
    [Abstract] [Full Text] [Related]

  • 3. Zolmitriptan versus sumatriptan for the acute oral treatment of migraine: a randomized, double-blind, international study.
    Gruffyd-Jones K, Kies B, Middleton A, Mulder LJ, Røsjø Ø, Millson DS.
    Eur J Neurol; 2001 May; 8(3):237-45. PubMed ID: 11328332
    [Abstract] [Full Text] [Related]

  • 4. Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet.
    Charlesworth BR, Dowson AJ, Purdy A, Becker WJ, Boes-Hansen S, Färkkilä M.
    CNS Drugs; 2003 May; 17(9):653-67. PubMed ID: 12828501
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine.
    Tuchman M, Hee A, Emeribe U, Silberstein S.
    CNS Drugs; 2006 May; 20(12):1019-26. PubMed ID: 17140280
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the efficacy of zolmitriptan and sumatriptan: issues in migraine trial design.
    Geraud G, Olesen J, Pfaffenrath V, Tfelt-Hansen P, Zupping R, Diener HC, Sweet R.
    Cephalalgia; 2000 Feb; 20(1):30-8. PubMed ID: 10817444
    [Abstract] [Full Text] [Related]

  • 7. Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial.
    Dowson AJ, Charlesworth BR, Purdy A, Becker WJ, Boes-Hansen S, Färkkilä M.
    CNS Drugs; 2003 Feb; 17(11):839-51. PubMed ID: 12921494
    [Abstract] [Full Text] [Related]

  • 8. Zolmitriptan is effective for the treatment of persistent and recurrent migraine headache.
    Mauskop A, Farkkila M, Hering-Hanit R, Rapoport A, Warner J.
    Curr Med Res Opin; 1999 Feb; 15(4):282-9. PubMed ID: 10640260
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Optimizing the dose of zolmitriptan (Zomig, 311C90) for the acute treatment of migraine. A multicenter, double-blind, placebo-controlled, dose range-finding study. The 017 Clinical Trial Study Group.
    Rapoport AM, Ramadan NM, Adelman JU, Mathew NT, Elkind AH, Kudrow DB, Earl NL.
    Neurology; 1997 Nov; 49(5):1210-8. PubMed ID: 9371896
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of rizatriptan and other triptans on the nausea symptom of migraine: a post hoc analysis.
    Lipton RB, Pascual J, Goadsby PJ, Massiou H, McCarroll KA, Vandormael K, Jiang K, Lines CR.
    Headache; 2001 Sep; 41(8):754-63. PubMed ID: 11576198
    [Abstract] [Full Text] [Related]

  • 17. Comparison of naratriptan and sumatriptan in recurrence-prone migraine patients. Naratriptan International Recurrence Study Group.
    Göbel H, Winter P, Boswell D, Crisp A, Becker W, Hauge T, Mihout B, Niewold J, Tørring J.
    Clin Ther; 2000 Aug; 22(8):981-9. PubMed ID: 10972634
    [Abstract] [Full Text] [Related]

  • 18. Treatment of nonresponders to oral sumatriptan with zolmitriptan and rizatriptan: a comparative open trial.
    Mathew NT, Kailasam J, Gentry P, Chernyshev O.
    Headache; 2000 Jun; 40(6):464-5. PubMed ID: 10849042
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of ADAM Zolmitriptan for the Acute Treatment of Difficult-to-Treat Migraine Headaches.
    Tepper SJ, Dodick DW, Schmidt PC, Kellerman DJ.
    Headache; 2019 Apr; 59(4):509-517. PubMed ID: 30698272
    [Abstract] [Full Text] [Related]

  • 20. Acute treatment of migraine with zolmitriptan 5 mg orally disintegrating tablet.
    Spierings EL, Rapoport AM, Dodick DW, Charlesworth B.
    CNS Drugs; 2004 Apr; 18(15):1133-41. PubMed ID: 15581383
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.